MENU

XRTX XORTX Therapeutics Inc. Forecast, Technical & Fundamental Analysis

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease... Show more

XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3710 - 33rd Street NW
Phone
+1 403 607-2621
Employees
12
Web
https://www.xortx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCPT25.190.23
+0.92%
Four Corners Property Trust
CSHR4.220.03
+0.72%
Coinshares Plc
PW9.320.02
+0.22%
Power REIT
PKX51.22-1.06
-2.03%
POSCO Holdings
NRXS6.88-0.26
-3.64%
Neuraxis

XRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
-4.21%
BCDA - XRTX
43%
Loosely correlated
+2.51%
KPRX - XRTX
28%
Poorly correlated
-1.57%
BYSI - XRTX
26%
Poorly correlated
-3.36%
CLNN - XRTX
26%
Poorly correlated
+0.32%
MIST - XRTX
26%
Poorly correlated
-2.29%
More
XORTX Therapeutics (XRTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com